Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00570 TRAD CHI MED
RTNominal down4.280 -0.020 (-0.465%)
Others

22/05/2019 10:38

Trad Chi Med (00570) major shareholder buys more shares

[ET Net News Agency, 22 May 2019] China Traditional Chinese Medicine Holdings Co.
Limited (00570) said its controlling shareholder, China National Pharmaceutical Group
Corporation (CNPGC), has acquired 5 million shares of the company on the market through
its wholly-owned subsidiary, Sinopharm Group Hongkong Co. Limited (Sinopharm Hongkong) on
21 May 2019. The average price of the increase in shareholding is approximately HK$4.08
per share.
CNPGC through Sinopharm Hongkong indirectly now holds 1.62 billion shares of the
company, representing approximately 32.16% of the total issued share capital of the
Company.
Based on the confidence of sustainable growth of the company, CNPGC plans to further
increase its shareholding in the company by acquiring in aggregate no more than 50 million
shares of the company through Sinopharm Hongkong during the six-month period commencing
from 21 May 2019 with its own funds. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.